
Advertise on podcast: PsychRounds: The Psychiatry Podcast
Rating
4.8from
This podcast has
121 episodes
Language
EnglishExplicit
No
Date created
2023/12/05
Latest episode
2026/11/04
Average duration
30 min.
Release period
18 days
Description
Welcome to Psych Rounds, the podcast tailored for psychiatry residents and students. Join us, three psychiatric resident physicians, as we delve into quick insights, interviews, and practical tips essential for educational practice. Subscribe for a straightforward yet informal approach to psychiatric knowledge. Contact us: [email protected] Instagram: https://www.instagram.com/psychrounds/
Unlock PsychRounds: The Psychiatry Podcast podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from PsychRounds: The Psychiatry Podcast podcast
A Validity-Based Diagnostic Hierarchy with Dr. Mark Ruffalo and Dr. Ronald Pies
2026/11/04
Today, we welcome back a former guest, Dr. Mark Ruffalo, and joining him is his colleague and co-author, Dr. Ronald Pies. We will be discussing their recently published article, The Need For A Validity-Based Hierarchy In DSM-6.
Article: https://pubmed.ncbi.nlm.nih.gov/42908074/
Dr. Ruffalo Website: https://www.drruffalo.com/
Dr. Pies Psychiatric Times Profile: https://www.psychiatrictimes.com/authors/ronald-w-pies-md
A New Long-Acting Injectable: Olanzapine (Zyprexa) Weltruza
2026/10/21
Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza.
References:
https://pubmed.ncbi.nlm.nih.gov/41632432/
https://pubmed.ncbi.nlm.nih.gov/42198294/
https://www.tevapharm.com/news-and-media/latest-news/new-long-term-safety-data-from-the-completed-phase-3-solaris-trial-support-the-potential-of-olanzapine-la/
Pharmacogenetic Testing in Psychiatry
2026/10/07
Welcome back, everyone! We’re back after PRITE, and today we’re discussing pharmacogenetic testing.
GLP-1 Agonists (Ozempic, Wegovy) in Psychiatry
2026/09/16
Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry.
Sources:
https://pubmed.ncbi.nlm.nih.gov/42247271/
https://pmc.ncbi.nlm.nih.gov/articles/PMC11441540/
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2838205
https://pubmed.ncbi.nlm.nih.gov/42070571
https://pubmed.ncbi.nlm.nih.gov/41806782/
Landmark Studies: The STAR*D Trial
2026/09/02
We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial.
References:
https://pubmed.ncbi.nlm.nih.gov/12778843/
https://pubmed.ncbi.nlm.nih.gov/19880458/
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482026
https://pubmed.ncbi.nlm.nih.gov/15061154/
https://pubmed.ncbi.nlm.nih.gov/20370962/
https://pubmed.ncbi.nlm.nih.gov/37491091/
Dogs in Mental Health with Dr. Nancy Gee: A Biopsychosocial Approach
2026/08/19
We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science with the leading expert on the subject.
Dr. Nancy Gee Profile: https://medschool.vcu.edu/about/portfolio/details/geen2/
References:
Dogs Supporting Human Health and Well-Being: A Biopsychosocial Approach:
https://pubmed.ncbi.nlm.nih.gov/33860004/
Randomized Controlled Trials: https://pmc.ncbi.nlm.nih.gov/articles/PMC12728353/, https://pmc.ncbi.nlm.nih.gov/articles/PMC11714157/
Centanafadine (Simtriyo): A New Medication for ADHD
2026/08/05
Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD.
References
https://pmc.ncbi.nlm.nih.gov/articles/PMC12314114/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/
https://pubmed.ncbi.nlm.nih.gov/31776871/
https://pubmed.ncbi.nlm.nih.gov/40619095/
https://pubmed.ncbi.nlm.nih.gov/28731336/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9426730/
Landmark Studies: The CATIE Trial
2026/07/22
Today we're starting a new type of series - looking at some of the most seminal studies in psychiatry. We're going to start with the CATIE Trial, which was published in 2005.
References:
https://www.nejm.org/doi/full/10.1056/NEJMoa051688
https://pubmed.ncbi.nlm.nih.gov/19594194/
https://pubmed.ncbi.nlm.nih.gov/17924259/
https://pubmed.ncbi.nlm.nih.gov/17286522/
https://www.nejm.org/doi/full/10.1056/NEJMoa061240
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/209844
The Rising Use of Recreational Kratom
2026/07/08
Apologies for our little hiatus - a couple of us had cross-country moves in June. But we're back! Today we have an episode on the rising use of recreational Kratom and pertinent tidbits to know from a psychiatry standpoint.
References:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8924421/
https://www.ncbi.nlm.nih.gov/books/NBK585120/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10846393/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10177737/
Modafinil (Provigil)
2026/06/03
Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry.
References:
Provigil (modafinil) [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/drugsatfdadocs/label/2015/020717s037s038lbl.pdf
Schwartz JR. Modafinil in the treatment of excessive sleepiness. Drug Des Devel Ther. 2009;2:71–85.
Kaplan S, Goehring EL Jr, Engel T, et al. Cardiovascular outcomes associated with modafinil in patients with obstructive sleep apnea. Pharmacoepidemiol Drug Saf. 2018;27(11):1182–1190. doi:10.1002/pds.4642
Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–738. doi:10.1016/S2215-0366(18)30269-4
Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2013;74(11):1101–1107. doi:10.4088/JCP.13r08560
Bahji A, Mesbah-Oskui L. Comparative efficacy and safety of stimulant-type medications for depression: a systematic review and network meta-analysis. J Affect Disord. 2021;292:416–423. doi:10.1016/j.jad.2021.05.119
Nunez NA, Singh B, Jorgensen A, et al. Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: a meta-analysis of randomized controlled trials. Bipolar Disord. 2020;22(2):109–120. doi:10.1111/bdi.12859
Naltrexone
2026/05/20
Welcome Back! Today we are discussing the medication Naltrexone and its uses in psychiatry.
References:
https://www.ncbi.nlm.nih.gov/books/NBK534811/
https://pubmed.ncbi.nlm.nih.gov/24825644/
https://pubmed.ncbi.nlm.nih.gov/26798982/
https://www.nejm.org/doi/full/10.1056/NEJMct0801733
https://pubmed.ncbi.nlm.nih.gov/26798982/
Placebo Effect and Response in Psychiatry
2026/05/06
Welcome back! Today, we will be discussing the placebo effect.
References:
https://pubmed.ncbi.nlm.nih.gov/16503356/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003660/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556377/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714297/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694178/
https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast/2018/11/19/understanding-placebo
Amantadine (Symmetrel)
2026/04/08
Welcome back! Today we are talking all about Amantadine, and it's uses in psychiatry.
VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
2026/03/21
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).
References:
https://pubmed.ncbi.nlm.nih.gov/41626799/
https://www.ncbi.nlm.nih.gov/books/NBK548187/
https://pubmed.ncbi.nlm.nih.gov/41626799/
A DSM Conversation with Dr. Allen Frances
2026/02/25
We are back with another special guest episode! Please welcome Dr. Allen Frances, who was intricately involved in the formation of both the DSM III and DSM IV, the latter of which he served as chair.
https://x.com/AllenFrancesMD
https://www.amazon.com/stores/author/B001HO76FU
https://www.psychiatrictimes.com/authors/allen-frances-md
Podcast reviews
Read PsychRounds: The Psychiatry Podcast podcast reviews
The chicken goes moo 2026/10/27
Deep dive
I appreciate the details. Very useful information to apply clinically.
I would love an episode about psychiatric polypharmacy do’s and dont’s
PA in Texas 2026/07/22
Love the Landmark Studies
Great adjunct to the 50 Studies book, please do more!
Nameddddddddddd 2026/05/19
As any patient, this is really good!
As someone who has seen a lot of drs, it has been really helpful to “virtually” meet all the different ways of approaching a patient. Some, like posit...
Anxious Ken 2026/03/22
Not My Specialty
I am not a mental health professional. I am a retired ophthalmologist. However, I have suffered from a lifetime of mental health challenges. I came ac...
ChicagoPA 2025/10/02
Practical knowledge
Organized, unbiased, clear, quality content that is easy to listen to. Thanks for your thoughtful work on these episodes. Very much appreciate by this...
SoCalGlen 2025/09/30
Bravo!
I am a PMHNP and I listen to these episodes on the way to work. Great to have psychotropic station on the radio dial. I am now encouraging my NP resid...
PollyMildenberger 2025/09/10
PMHNP
Love all of the information and professional perspectives provided in this podcast. It is such a helpful supplement to the knowledge gained in educati...
psychiadree 2025/07/31
Great podcast
Fifth year child fellow- studying for general boards. This is perfect review for my runs/drives to work. Wish I'd discovered it sooner.
sonja-huang 2025/06/26
Non-MD listener
Although this podcast is designed for a medical audience, listening has proved intensely healing for me: a law student with no medical training. Your ...
Suvorovpk69 2025/05/29
Great Info
Strong material, great for board prep and plenty of clinical pearls. Enjoy the Interventional content, which is lacking in other podcasts.
Podcast sponsorship advertising
Start advertising on PsychRounds: The Psychiatry Podcast relevant audience podcasts
You may also like to advertise on these Podcasts

4.947999419
The Shawn Ryan Show
Shawn Ryan

4.5185359
Who, When, Wow!
Tinkercast | Wondery

4.6688781131
Armchair Expert with Dax Shepard
Armchair Umbrella

4.9554862201
The MeidasTouch Podcast
MeidasTouch Network

4.639655
Only Murders in the Building Podcast
Straw Hut Media

4.7833521
The Home Service Expert Podcast
Tommy Mello: $200 Million Founder|Forbes, Inc., Entrepreneur Columnist

4.443671371
Something You Should Know
Mike Carruthers | OmniCast Media

4.7906254
Everything is Fine
Jennifer Romolini and Kim France

4.610916582
Serialously with Annie Elise
Annie Elise & Audioboom Studios

4.41171483
The Outlier Health Podcast
Matt Frazier, Matt Tullman, Isabelle Caputo, and Doug Hay